Provided by Tiger Trade Technology Pte. Ltd.

LISATA THERAPEUTICS INC

1.74
+0.270018.37%
Post-market: 1.800.0600+3.45%19:58 EDT
Volume:3.04M
Turnover:5.35M
Market Cap:15.68M
PE:-1.06
High:2.56
Open:2.50
Low:1.50
Close:1.47
52wk High:5.07
52wk Low:0.9875
Shares:9.01M
Float Shares:6.49M
Volume Ratio:19.79
T/O Rate:46.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6418
EPS(LYR):-1.9100
ROE:-101.66%
ROA:-56.74%
PB:1.90
PE(LYR):-0.91

Loading ...

Lisata Therapeutics - on July 31, Commenced Legal Action Against Kuva Labs and Kuva Acquisition Corp. for Breach of Merger Agreement - SEC Filing

THOMSON REUTERS
·
Aug 04

Lisata Therapeutics terminates merger with Kuva Labs

TIPRANKS
·
Jul 27

Lisata Therapeutics Shares Fall After Terminating Kuva Labs Deal

MT Newswires Live
·
Jul 25

Lisata Therapeutics - Board to Assess Strategic Options Including Reverse Merger or Asset Sales - SEC Filing

THOMSON REUTERS
·
Jul 25

Lisata Therapeutics - Terminates Merger Agreement with Kuva Labs on July 24, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 25

U.S. Stocks on the Move-duke Robotics, Tesla, Hasbro

Reuters
·
Jul 22

Lisata Tumbles as Buyer Kuva Fails to Fund Takeover on Time

Reuters
·
Jul 21

Lisata Therapeutics - Extends Merger Agreement Outside Date to July 21, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 17

Lisata Therapeutics, Kuva Labs Extend Merger Agreement Outside Date to July 21

Reuters
·
Jul 17

Lisata says Kuva Labs launches tender offer at USD 4 per share plus CVR

Reuters
·
Jun 10

Lisata Therapeutics - Deal Expected to Close in Q3 2026

THOMSON REUTERS
·
Jun 10

Press Release: Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.

Dow Jones
·
Jun 10

Lisata Therapeutics - Company to Waive Claims for Missed $250,000 Payment IF Conditions Met - SEC Filing

THOMSON REUTERS
·
Jun 09

Lisata Therapeutics - Outside Date for Merger Extended to July 17, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 09

Lisata Therapeutics, Kuva Labs extend merger offer start date to June 10

Reuters
·
Jun 09

Lisata says Kuva Labs delays start of tender offer after missing June 1 date

Reuters
·
Jun 01

Stocks to Watch: Oculis, Lisata, Healthy Choice Wellness

Dow Jones
·
May 30

BRIEF-Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR

Reuters
·
May 30

Lisata Therapeutics - Amends Merger Offer Price to $4 per Share Plus CVR - SEC Filing

THOMSON REUTERS
·
May 30

Lisata Therapeutics, Kuva Labs cut tender offer price to $4, boost CVR payout to up to $3

Reuters
·
May 30